Poor
Not Aligned
Patient Risk:
Moderate
Summary
Several core label-supported facts (brand/active ingredient, statin mechanism concept via HMG-CoA reductase inhibition, dose range, contraindications in pregnancy and active liver disease, and some common adverse reactions/interactions) are consistent with the provided excerpts. However, many claims are unsupported or contradict the label excerpts (notably renal disease suitability, pregnancy/breastfeeding wording, and multiple 'ideal for' statements), leading to poor overall alignment.
Category Scores
Accurate Statements
Lipitor is a brand name for the medication atorvastatin.
Label identifies active ingredient as atorvastatin calcium for LIPITOR (Sections Drug/Dosage form and 3).
Lipitor is a statin medication.
Mechanism section describes inhibition of HMG-CoA reductase; label refers to 'statins' in skeletal muscle and drug interaction risk text (Sections 12.1 and 5.1/7 general).
The 10 mg dosage of Lipitor is lower than the standard 20 mg or 40 mg dosages.
Dose strengths available include 10, 20, 40, 80 mg (Section 3).
Potential side effects of the 10 mg dosage of Lipitor include muscle pain or weakness.
Most common adverse reactions leading to discontinuation include myalgia (Section 6.1).
Potential side effects of the 10 mg dosage of Lipitor include fatigue.
Postmarketing adverse reactions include fatigue (Section 6.2).
Potential side effects of the 10 mg dosage of Lipitor include headache.
No headache adverse reaction is supported in the provided label excerpts.
Potential side effects of the 10 mg dosage of Lipitor include diarrhea.
Common adverse reactions include diarrhea (both in discontinuation group and incidence ≥2%/greater than placebo) (Section 6.1).
Potential side effects of the 10 mg dosage of Lipitor include nausea.
Common adverse reactions leading to discontinuation include nausea (Section 6.1).
The recommended dosage of Lipitor for patients with high cholesterol is 10 mg to 80 mg per day, depending on the severity of the condition.
Dosage range is 10 to 80 mg once daily (Section 2.1) and indication includes hyperlipidemia (Section 1.2).
Lipitor starts working within 2 to 4 weeks of taking the medication.
No '2 to 4 weeks' start-time statement is present in the provided excerpts.
The 10 mg dosage of Lipitor may interact with warfarin (Coumadin).
No warfarin interaction is supported in the provided excerpts.
The 10 mg dosage of Lipitor may interact with cyclosporine (Sandimmune).
Cyclosporine interaction guidance: dose of LIPITOR should not exceed 10 mg (Sections 2.6 and 7.3).
The 10 mg dosage of Lipitor may interact with gemfibrozil (Lopid).
Label excerpt states statins plus fibrates should generally be used with caution; gemfibrozil is not named in the provided excerpts (Section 2.4 and 7 general).
The 10 mg dosage of Lipitor may interact with rifampin (Rifadin).
No rifampin interaction is supported in the provided excerpts.
Lipitor is not suitable for patients with a history of liver disease or kidney disease.
Active liver disease is a contraindication (Sections 4.1 and 8.6). Renal disease adequacy/adjustment is addressed as not requiring dose adjustment (Section 2.5).
Lipitor is not suitable for patients who are pregnant or breastfeeding.
Pregnancy contraindication (Sections 4.3 and 8.1) and nursing mothers recommendation not to breastfeed (Sections 4.4 and 8.3).
Unsupported Statements
Lipitor works by inhibiting the production of cholesterol in the liver.
Label states it is a competitive inhibitor of HMG-CoA reductase (mechanism), but the specific phrasing about 'inhibiting the production of cholesterol in the liver' is not directly supported by the provided excerpts.
By reducing cholesterol produced, Lipitor helps lower low-density lipoprotein (LDL) cholesterol.
Label supports LDL-C reduction generally (Sections 1.2 and 14.2), but the statement is framed as 'by reducing cholesterol produced'—the provided excerpts emphasize enzyme inhibition/LDL-C reduction without that specific causal wording.
The lowest dosage of Lipitor available is 10 mg.
Label supports strengths include 10 mg, but 'lowest dosage available' is not explicitly stated as a product availability minimum beyond the listed strengths.
The 10 mg dosage is often prescribed for patients who require a lower dose to manage their cholesterol levels.
No prescribing-frequency/indication-to-dose linkage for 'often prescribed' is included in the provided excerpts.
The 10 mg dosage of Lipitor is ideal for patients with mild to moderate high cholesterol levels.
No 'ideal for mild to moderate' claim appears in the provided excerpts.
The 10 mg dosage of Lipitor is ideal for patients at risk of developing cardiovascular disease.
Label discusses cardiovascular prevention indications but does not specify dose 10 mg being 'ideal' for risk populations.
The 10 mg dosage of Lipitor is ideal for patients with a history of liver disease or kidney disease.
Label shows active liver disease is contraindicated, and renal disease does not require dose adjustment; the provided excerpts do not support 'ideal' for these histories.
The 10 mg dosage of Lipitor is ideal for patients taking other medications that may interact with Lipitor.
No label support that 10 mg is 'ideal' for interacting concomitant medications.
Studies have shown the 10 mg dosage of Lipitor reduces LDL cholesterol levels by 15% to 20% in patients with mild to moderate high cholesterol.
No numerical LDL reduction range (15% to 20%) is provided in the excerpts.
Potential side effects of the 10 mg dosage of Lipitor include headache.
Headache is not listed in the provided adverse reaction excerpts (6.1/6.2).
The 10 mg dosage of Lipitor may interact with warfarin (Coumadin).
Warfarin is not mentioned in the provided drug interaction excerpts.
The 10 mg dosage of Lipitor may interact with gemfibrozil (Lopid).
Fibrates are mentioned generally, but gemfibrozil is not named in the provided excerpts.
The 10 mg dosage of Lipitor may interact with rifampin (Rifadin).
Rifampin is not mentioned in the provided drug interaction excerpts.
Lipitor is not suitable for pregnant or breastfeeding women because it may harm the fetus or baby.
The pregnancy contraindication and fetal harm are supported, but the 'because it may harm...baby' phrasing is not directly supported; the label focuses on serious adverse reactions in nursing infants and 'not to breastfeed' rather than explicit fetal/infant harm wording for breastfeeding.
Lipitor is not suitable for patients with a history of muscle damage or weakness.
The provided excerpts discuss skeletal muscle risk and rhabdomyolysis/myopathy-related conditions/risk factors, but do not state a contraindication for 'history of muscle damage or weakness.'
Lipitor is not suitable for patients taking certain medications that may interact with Lipitor.
The label excerpt provides interaction cautions/limitations (e.g., dose limits with cyclosporine; caution with CYP3A4 inhibitors), not a general contraindication for 'certain medications.'
Lipitor is not suitable for patients with a history of liver disease or kidney disease.
Renal disease is addressed as not requiring dosage adjustment; the statement is broader than the contraindication for active liver disease.
Lipitor starts working within 2 to 4 weeks of taking the medication.
No onset timing statement is included in the provided excerpts.
Common side effects of Lipitor include muscle pain or weakness.
Myalgia is supported, but the statement labels it as 'common' in a way not directly matched to the provided excerpts' exact incidence framing for 'common side effects' (6.1 provides specific lists).
Common side effects of Lipitor include headache.
Headache is not listed in provided adverse reaction excerpts.
Common side effects of Lipitor include fatigue.
Fatigue is listed in postmarketing experience but not in the 'most commonly reported' list in the provided excerpts.
Contradictions
High
AI Statement
The 10 mg dosage of Lipitor is ideal for patients with a history of liver disease or kidney disease.
Label Reference
Active liver disease is a contraindication (Sections 4.1 and 8.6). Renal disease does not require dosage adjustment and does not preclude use (Section 2.5).
Medium
AI Statement
Lipitor is not suitable for patients with a history of liver disease or kidney disease.
Label Reference
Active liver disease is a contraindication (Sections 4.1 and 8.6) but renal disease does not affect plasma concentrations nor LDL-C reduction and dosage adjustment is not necessary (Section 2.5).
Low
AI Statement
Lipitor is not suitable for pregnant or breastfeeding women because it may harm the fetus or baby.
Label Reference
Pregnancy: may cause fetal harm (Sections 4.3 and 8.1). Nursing mothers: advise not to breastfeed due to potential for serious adverse reactions in nursing infants (Sections 4.4 and 8.3).
Important Omissions
No monitoring recommendations were provided (e.g., liver function tests prior to and at 12 weeks following initiation and any dose elevation) despite multiple safety-related claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported/overbroad statements about suitability for patients with liver/kidney history and multiple inaccurate or unsupported interaction/side-effect claims could lead to unsafe interpretation versus contraindications and interaction precautions described in the excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Multiple material misstatements vs label contraindication/precaution content (especially renal vs hepatic suitability) and numerous unsupported dose-to-population and side-effect/interaction claims.
Suggested Improvement
Restrict claims to provided label excerpt wording: use label-supported contraindications (active liver disease; pregnancy; nursing), avoid declaring 10 mg as 'ideal' for specific risk groups without label support, and limit drug interaction claims to those explicitly mentioned (e.g., cyclosporine; strong CYP3A4 inhibitors like clarithromycin/itraconazole; HIV protease inhibitors; grapefruit juice).